Brief: Japan Tobacco Terminates Agreements On Exclusive Rights To Develop, Commercialize And Market Six Anti-HIV Drugs In Japan

Torii Pharmaceutical Co

29/11/2018 06:06

Nov 29 (Reuters) - Japan Tobacco Inc  2914.T :
    * TERMINATES AGREEMENTS ON EXCLUSIVE RIGHTS TO DEVELOP,
COMMERCIALIZE AND MARKET OF SIX ANTI-HIV DRUGS IN JAPAN
    * TERMINATES AGREEMENTS WITH GILEAD SCIENCES UNDER WHICH
GILEAD
GRANTS AN EXCLUSIVE LICENSE TO JT TO DEVELOP AND COMMERCIALIZE
SIX ANTI-HIV DRUGS IN JAPAN
    * ALSO TERMINATES LICENSE AGREEMENTS WITH TORII
PHARMACEUTICAL
UNDER WHICH JT GRANTS TORII THE EXCLUSIVE RIGHTS TO MARKET THE
CURRENT HIV DRUGS IN JAPAN

Source text for Eikon:  urn:newsml:reuters.com:*:nTSWc6c216
Further company coverage:  2914.T 

 (Reporting By Chris Gallagher)
 ((chris.gallagher@thomsonreuters.com;))